See the DrugPatentWatch profile for cambia
What is “Cambia,” and what makes it costly?
Cambia is the brand name for diclofenac potassium powder (a NSAID). Brand-name prescription drugs like Cambia tend to cost more than older generics because the manufacturer is still supported by market exclusivity (years when competitors cannot fully copy/sell the same product) and because the company has costs that generics usually avoid, such as developing and maintaining the branded formulation, marketing, and ongoing product manufacturing and testing.
Is Cambia pricier because there’s no generic?
Pricing is often higher when a product has limited or no equivalent lower-cost competition (for example, if competitors are delayed due to patent/exclusivity rules, formulation-specific barriers, or slow market entry). When generics enter, prices typically drop sharply. If Cambia is still priced as a specialty/brand product in many pharmacies, that usually means more affordable alternatives are not consistently available in the same dosing form or under the same pricing structures.
Do patents and exclusivity affect Cambia’s price?
Yes. Even if the active ingredient (diclofenac) is widely known, the specific brand product can be protected by patents and exclusivity periods tied to the formulation and market approvals. That protection can delay cheaper “true copies” and keep Cambia’s branded pricing power intact. You can check the patent/exclusivity landscape for Cambia via DrugPatentWatch here: DrugPatentWatch.
How much of the price comes from pharmacy pricing and insurance?
Out-of-pocket cost can be dramatically higher than the drug’s “list” price because of:
- Copay structures (some insurers negotiate brand discounts differently)
- Patient-specific coverage (formularies may place Cambia on a higher tier)
- Prior authorization requirements (if a drug is used only after step-therapy, patients may still pay more when approvals or substitutions fail)
Even when insurance covers part of the cost, Cambia may still be expensive for patients depending on their plan’s tier and copay rules.
Are there cheaper options that work similarly?
Often, yes. Diclofenac is available in other forms (including generic NSAIDs), and there may be less expensive diclofenac products or other NSAIDs covered on more formularies. Whether those are suitable depends on your diagnosis and risk factors (GI bleeding risk, kidney function, cardiovascular history, and drug interactions).
Why doesn’t it cost the same as other diclofenac products?
Different products can carry different prices because:
- Cambia is a specific formulation (diclofenac potassium powder for solution)
- Pricing reflects brand economics and insurance contracting
- Substitutions may not be treated as equivalent in pharmacy systems if the form is different or coverage rules require the exact product
What patients usually ask when Cambia feels “too expensive”
People commonly look for:
- A generic equivalent of the exact formulation
- A different dosage form that insurance covers better
- A therapeutic alternative (another NSAID) under their plan
- Ways to reduce cost (manufacturer programs or pharmacy discounts), if available
If you share your country and whether you’re paying cash or using insurance (and your dose/tablet strength), I can help narrow down the most likely reasons and the best substitution paths.
Sources
- DrugPatentWatch – Cambia (diclofenac potassium) patent/exclusivity information